Healthcare -
Biotechnology - NASDAQ - US
$ 1.255
-13.8 %
$ 355 M
Market Cap
-1.81
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Erasca, Inc.
| Revenue | 0 |
| Cost Of Revenue | 0 |
| Gross Profit | 0 |
| Operating Expenses | 180 M |
| Operating Income | -180 M |
| Other Expenses | -17.9 M |
| Net Income | -162 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|---|
| REVENUE | ||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | ||||||
| Cost Of Revenue | 0 | 3.7 | 2.6 | 0.8 | 0.5 | 0.3 |
| Gross Profit | 0 | (3.7) | (2.6) | (0.8) | (0.5) | (0.3) |
| OPERATING INCOME | ||||||
| Operating Expenses | 179.6 | 141.5 | 145.4 | 96.5 | 37.5 | 13.3 |
| Selling, General and Administrative Expenses | 41.7 | 37.7 | 33.0 | 22.6 | 8.0 | 3.7 |
| Research and Development Expenses | 112.4 | 103.8 | 112.5 | 73.9 | 29.6 | 9.6 |
| Operating Income | (179.6) | (141.5) | (247.4) | (124.9) | 34.2 | (13.3) |
| PRE-TAX INCOME | ||||||
| Interest Income Expense | 0 | 0 | 201.4 | 0 | 0 | 0 |
| Total Other Income | 17.9 | 16.5 | 4.6 | 2.1 | 7.6 | 1.3 |
| Pre-Tax Income | (161.7) | (125.0) | (242.8) | (122.8) | (101.7) | (12.0) |
| NET INCOME | ||||||
| Tax Provision | 0 | 0 | (4.6) | 27.3 | 71.4 | (1.3) |
| Net Income | (161.7) | (125.0) | (238.2) | (150.1) | (173.1) | (10.7) |
| EPS | 0.0691 | 0.1 | 0.24 | 0.16 | 0.93 | 0.0113 |